Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mollie J. Baird"'
Autor:
Caroline B. Kurtz, Valerie Williams, Jeffrey M. Johnston, Robyn T. Carson, Stavros Tourkodimitris, James E. MacDougall, Lauren Nelson, Mollie J. Baird, Sheri Fehnel
Publikováno v:
Clinical and Experimental Gastroenterology
Lauren M Nelson,1 Valerie SL Williams,1 Sheri E Fehnel,1 Robyn T Carson,2 James MacDougall,3 Mollie J Baird,3 Stavros Tourkodimitris,2 Caroline B Kurtz,3 Jeffrey M Johnston31RTI Health Solutions, Durham, NC, USA; 2Forest Research Institute, Jersey Ci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a16359d70661aee72638da24e5aef949
https://www.dovepress.com/psychometric-validation-of-patient-reported-outcome-measures-assessing-peer-reviewed-article-CEG
https://www.dovepress.com/psychometric-validation-of-patient-reported-outcome-measures-assessing-peer-reviewed-article-CEG
Autor:
Mollie J. Baird, Sheri Fehnel, Allen W. Mangel, Caroline B. Kurtz, Claire Ervin, Robyn T. Carson, Jeffrey M. Johnston, S J Shiff
Publikováno v:
Clinical and Experimental Gastroenterology
Claire M Ervin,1 Sheri E Fehnel,1 Mollie J Baird,2 Robyn T Carson,3 Jeffrey M Johnston,2 Steven J Shiff,3 Caroline B Kurtz,2 Allen W Mangel11RTI Health Solutions, Research Triangle Park, NC, USA; 2Ironwood Pharmaceuticals, Inc., Cambridge, MA, USA; 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d7a872b5a0d513bd599163f99b3bac9
https://www.dovepress.com/assessment-of-treatment-response-in-chronic-constipation-clinical-tria-peer-reviewed-article-CEG
https://www.dovepress.com/assessment-of-treatment-response-in-chronic-constipation-clinical-tria-peer-reviewed-article-CEG
Autor:
Valerie Williams, Robyn T. Carson, Mollie J. Baird, Caroline B. Kurtz, Lauren Nelson, James E. MacDougall, Jeffrey M. Johnston, Sheri Fehnel, Stavros Tourkodimitris
Publikováno v:
Alimentary pharmacologytherapeutics. 40(3)
SummaryBackground Historically, measures of symptom severity of irritable bowel syndrome with constipation (IBS-C) in clinical trials have not met the evidence requirements described in the FDA guidance on patient-reported outcomes (PROs), which desc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a103a6659ecb30143f105a0753db9fa5
https://pubmed.ncbi.nlm.nih.gov/24943204
https://pubmed.ncbi.nlm.nih.gov/24943204
Autor:
Caroline B. Kurtz, William D. Chey, Anthony Lembo, Xinwei D. Jia, Mark G. Currie, Jeffrey M. Johnston, Mollie J. Baird, Harvey Schneier, James Z. Shao, Bernard J. Lavins, S J Shiff, James E. MacDougall, Donald A. Fitch
Publikováno v:
The American journal of gastroenterology. 107(11)
Linaclotide is a minimally absorbed peptide guanylate cyclase-C agonist. The objective of this trial was to determine the efficacy and safety of linaclotide treatment in patients with irritable bowel syndrome with constipation (IBS-C) over 26 weeks.T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2129ef4046b2e69321c425aa0399da91
https://pubmed.ncbi.nlm.nih.gov/23791794
https://pubmed.ncbi.nlm.nih.gov/23791794
Autor:
William D. Chey, Kelvin Shi, Xinming Hao, M Currie, Bernard J. Lavins, Mollie J. Baird, Eamonn Martin Quigley, D Fitch, Jeffrey M. Johnston, Harvey Schneier
Publikováno v:
Gut. 62:A140-A141
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ff3fd968235dc06804a33a1af23c983
https://doi.org/10.1136/gutjnl-2013-304907.315
https://doi.org/10.1136/gutjnl-2013-304907.315
Autor:
Jeffrey M. Johnston, Jessica L. Buono, Mollie J. Baird, Phil Sarocco, Robyn T. Carson, Stavros Tourkodimitris
Publikováno v:
Value in Health. 15:A330-A331
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89f5c80bdd890043cda90a4143721884
https://doi.org/10.1016/j.jval.2012.08.776
https://doi.org/10.1016/j.jval.2012.08.776
Autor:
Lauren Nelson, Robyn T. Carson, Mollie J. Baird, Jeffrey M. Johnston, Stavros Tourkodimitris, Valerie Williams, Sheri Fehnel
Publikováno v:
American Journal of Gastroenterology. 107:S590-S591
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6b929fa6a5924eaedd92b4543c34b36
https://doi.org/10.14309/00000434-201210001-01479
https://doi.org/10.14309/00000434-201210001-01479
Autor:
Stavros Tourkodimitris, Sheri Fehnel, Valerie A. Williams, Lauren Nelson, Jeffrey M. Johnston, Mollie J. Baird, Robyn T. Carson
Publikováno v:
American Journal of Gastroenterology. 107:S587-S588
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc49f2961c1dc675469849c09f344bec
https://doi.org/10.14309/00000434-201210001-01472
https://doi.org/10.14309/00000434-201210001-01472
Publikováno v:
Gut. 63:A198.1-A198
Introduction Linaclotide is a minimally absorbed guanylate cyclase-C agonist approved for treatment of IBS with constipation (IBS-C). IBS often results in diminished quality of life (QOL), including decreased sexual desire and activity. This post-hoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26b62d28ad480c3d1bebd161077a1a71
https://doi.org/10.1136/gutjnl-2014-307263.427
https://doi.org/10.1136/gutjnl-2014-307263.427
Autor:
Claire Ervin, Jeffrey M. Lackner, Mollie J. Baird, Lin Chang, Sheri Fehnel, Brennan Spiegel, Robyn T. Carson, Karen Lasch, Nancy J. Norton
Publikováno v:
Gastroenterology. 144:S-546
for the Development of Patient Reported Outcome Instruments Mollie J. Baird, MPH1; Robyn T. Carson, MPH2, Claire Ervin, MPH3; Lin Chang, MD4; Brennan Spiegel, MD4; Nancy J. Norton5; Jeffrey Lackner, PsyD6; Karen Lasch, MD7; and Sheri E. Fehnel, PhD3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e2e21b5556ef182dd29002ed48e9b89
https://doi.org/10.1016/s0016-5085(13)62027-2
https://doi.org/10.1016/s0016-5085(13)62027-2